{
    "eid": "2-s2.0-85085084310",
    "title": "The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post\u2013Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Surgery",
            "@code": "2746",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Transplantation",
            "@code": "2747",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Maneerat Chayanupatkul",
        "Divya B. Dasani",
        "Kristian Sogaard",
        "Thomas D. Schiano"
    ],
    "citedby-count": 12,
    "ref-count": 32,
    "ref-list": [
        "Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention",
        "Epidemiology and natural history of NAFLD and NASH",
        "Natural History of NAFLD/NASH",
        "NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances",
        "Prevalence and clinical associations of posttransplant fatty liver disease",
        "Non-alcoholic fatty liver disease in liver transplant recipients: another story of \u201cseed and soil",
        "Prevalence and risk factors of steatosis after liver transplantation and patient outcomes",
        "Noninvasive characterization of graft steatosis after liver transplantation",
        "NAFLD recurrence in liver transplant recipients",
        "Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis",
        "Transient elastography (FibroScan((R))) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease: where do we stand?",
        "Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease",
        "Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations",
        "Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C",
        "Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter",
        "Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation",
        "Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis",
        "Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C",
        "Recurrent or de novo allograft steatosis and long-term outcomes after liver transplantation",
        "Risk factors and clinical course for liver steatosis or nonalcoholic steatohepatitis after living donor liver transplantation",
        "Genetics of alcoholic liver disease and non-alcoholic steatohepatitis",
        "Non-alcoholic steatohepatitis with normal aminotransferase values",
        "Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)",
        "Long-term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis-related cirrhosis",
        "De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients",
        "Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation",
        "Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients",
        "Doppler ultrasound and transient elastography in liver transplant patients for noninvasive evaluation of liver fibrosis in omparison with histology: a prospective observational study",
        "Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: a meta-analysis",
        "Accuracy of vibration controlled transient elastography in liver transplant recipients",
        "Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease",
        "Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "@id": "60012981",
            "affilname": "Icahn School of Medicine at Mount Sinai",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012981",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}